HSA & ARQon active role in Medtech product development for local and global requirements
August 30, 2018
HSA has recently set up an Innovation Office, a regulatory advisor for product development, in pursuit of greater efficiency in the development and registration of therapeutic products. This will greatly shorten the time needed for product development by providing professional advice to relevant industries and create a more diverse market for clinical treatments. The Innovation Office is a move that will encourage key players to be more proactive in their development of clinical products and drive the progress of the medical industry.
ARQon has also released a Global Regulatory Strategy that will facilitate a smoother process of product development by helping companies understand the necessary regulatory requirements, the required resources and the estimated timeline to register and seek approval from the local authority of the countries of interest.